If you want a biotech then this is not for you. It is a hybrid.
A former research company dabbling in highly competitive retail marketing of beauty products. A totally different skill set IMO and as a result expensive mistakes have and will continue to be made and share holders will foot the bill as management adapt and refocus on new careers as marketing gurus.
Ann: Preliminary Final Report, page-113
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable